Search Results - "Rank, Doug"
-
1
Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturability
Published in Biotechnology and bioengineering (01-11-2011)“…A potent single digit picomolar fully human monoclonal antibody (hMAb) inhibitor with a high degree of specificity to the antigen of interest was identified…”
Get full text
Journal Article -
2
A series of pharmacokinetic studies of ceftaroline fosamil in select populations: Normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis
Published in Journal of clinical pharmacology (01-07-2014)“…Ceftaroline fosamil is a parenteral cephalosporin indicated for the treatment of acute bacterial skin and skin structure infections and community‐acquired…”
Get full text
Journal Article -
3
Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA-Specified End Points
Published in Open forum infectious diseases (01-04-2019)“…Hospital-acquired and ventilator-associated pneumonia (HAP/VAP; nosocomial pneumonia) due to Gram-negative pathogens are associated with significant morbidity…”
Get full text
Journal Article -
4
Phase 3, Randomized, Double-blind Noninferiority (NI) Study of Ceftazidime–Avibactam (CAZ-AVI) vs. Meropenem (MER) in the Treatment of Patients with Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP): Analyses of the REPROVE Study per US FDA Endpoints
Published in Open forum infectious diseases (01-10-2017)Get full text
Journal Article -
5
Novel small scale TFF cell retention device for perfusion cell culture systems
Published in BMC proceedings (14-12-2015)“…Perfusion processes have traditionally been used for the generation of unstable proteins in cell culture systems. The use of perfusion for production of stable…”
Get full text
Journal Article